Ullman Comments on FDA’s Failure to Regulate the CBD Market

June 16, 2021 | Compliance Investigations & White Collar

Marc Ullman was quoted in the NutraIngredients-USA article, “COVID-19 and legal chaos dent CBD market – but Congress and a stronger economy offer hope.”

The article discusses the state of the CBD market amid the COVID-19 pandemic and legal battles.

Ullman says the market is in disarray due to the FDA’s inaction.

Read the full article. 

Share this article:

Related News


Get legal updates and news delivered to your inbox